Clinical Trial Update: Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil) [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing the bioavailability and safety of two fixed-dose 18 mg ivermectin tablets (LICONSA S.A.) versus a 6 mg ivermectin tablet (REVECTINA) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis

Drugs mentioned

• Ivermectin 18 mg fixed-dose tablet (Ivermectin)
• REVECTINA (Ivermectin 6 mg tablet) (Ivermectin)

Snippet

Sponsor: Insud Pharma | Conditions: Helminthiasis | Phase 1 | Status: COMPLETED